MyAverix Finance
F · Healthcare
OPTIBIOTIX HLTH PLC LS-02 (OB3)
Biotechnology
OPTIBIOTIX HLTH PLC LS-02 (OB3) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $6.52M, P/E ratio is 18.00, net margin is -16.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for OB3
OPTIBIOTIX HLTH PLC LS-02 (OB3) — FAQ
What is OPTIBIOTIX HLTH PLC LS-02's market cap?
OPTIBIOTIX HLTH PLC LS-02 (OB3) has a reported market cap of $6.52M (data as of 2026-03-30).
What is OB3's P/E ratio?
The price-to-earnings (P/E) ratio for OPTIBIOTIX HLTH PLC LS-02 (OB3) is 18.00 (data as of 2026-03-30).
Does OPTIBIOTIX HLTH PLC LS-02 pay a dividend?
Dividend yield is not available in the current snapshot for OPTIBIOTIX HLTH PLC LS-02 (OB3). Check the MyAverix Finance app for the latest dividend data.
What sector is OPTIBIOTIX HLTH PLC LS-02 in?
OPTIBIOTIX HLTH PLC LS-02 (OB3) is classified in the Healthcare sector (Biotechnology industry).
What exchange is OB3 listed on?
OB3 is listed on F.
What is OPTIBIOTIX HLTH PLC LS-02's net margin?
OPTIBIOTIX HLTH PLC LS-02 (OB3) reports a net margin of -16.6% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.